The ISAR InflEx Trial (Inflammation and Exercise)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorDepartment of Cardiology German Heart Center Munich TUM University Hospital

About this trial

A sedentary lifestyle and obesity are associated with chronic low-grade inflammation and an elevated risk of cardiovascular disease (CVD). This study aims to systematically characterize and compare the effects of three distinct exercise modalities - moderate-intensity, vigorous-intensity, and short-duration maximal exercise - each differing in duration and intensity, on systemic inflammation and immune function. The study investigates the potential of exercise as an effective anti-inflammatory intervention for the prevention of CVD.

Eligibility criteria

Qualifiers

BMI 25.0 - 30.0 kg/m²

age 18 - 45 years

informed consent

no regular physical activity (≤1x/week of structured exercise)

Disqualifiers

any acute or chronic illness

pregnancy and breastfeeding

active smoking

Regular use of medication

Trial design

Treatments tested in this trial

  • moderate-intensity exercise
  • vigorous-intensity exercise
  • short bouts of maximal exercise

Treatment groups

33 Participants
are divided into 3 treatment groups

Locations

1
German Heart Centre80636, MünchenBavaria, Germany

Sponsors and collaborators

Department of Cardiology German Heart Center Munich TUM University Hospital

Lead sponsor

The German Heart Foundation

Collaborator

Klinikum rechts der Isar Technische Universität München

Collaborator